To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Manufacturing API, Drugs, and Excipients in America Act. S. 2082. 117th
Cong., 1st
sess., Introduced in Senate June 16, 2021. https://www.govinfo.gov/app/details/BILLS-117s2082is.
APA
Congress, Senate (2021, June 16). Manufacturing API, Drugs, and Excipients in America Act (S. 2082 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-117s2082is.
MLA
United States, Congress, Senate. Manufacturing API, Drugs, and Excipients in America Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-117s2082is. 117th Congress, S. 2082, Introduced in Senate 16 Jun. 2021.
Bluebook
S.2082 - 117th Congress (2021-2022): Manufacturing API, Drugs, and Excipients in America Act, S.2082, 117th Cong. (2021), https://www.govinfo.gov/app/details/BILLS-117s2082is.
